What will convince payers & investors to embrace digital therapeutics?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Rigorous Data Are Key to Convince Payers, Investors in the World of Digital Therapeutics Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers. Sponsored Content Transforming Claims Denial with AI Presented by Experian Health Hospitals and health systems, overburdened by pandemic-induced staff shortages, are in need of tech to improve workflows, reduce stress and save money. The claims denial process, which is a significant time suck and prone to errors, is ripe for innovation. Learn More>> "Riveting Panel Discussions" A direct quote from an INVEST Digital Health attendee last year. Have you seen our agenda for this year? Buckle up for another riveting year of speakers and panel discussions around healthcare's most pivotal discussions, pain points, ROI and evolution. Join us October 26th at Pegasus Park in Dallas, TX. Save $200 [Ends Friday] - Register Now

Featured News

How to Improve Poor Data Quality Across the Healthcare Ecosystem and Make Workflows More Manageable The webinar, sponsored by Intelligent Medical Objects, will explore the impact of poor data quality and methods to improve patient data quality. It will also highlight healthcare industry employee burnout and how to improve retention. The Biden Administration Proposes Rule To Improve Mental Health Parity A new proposed rule by the Biden-Harris Administration would require health plans to improve their analyses of their mental health benefits and make clear that they cannot engage in practices that make it more difficult for members to access mental health support compared to physical health. UpLift Secures $10.7M To Expand Access to Behavioral Health Services UpLift's Series A funding round was led by Ballast Point Ventures and included participation from Kapor Capital, Front Porch Ventures and B Capital. In total, UpLift has raised more than $22 million. Astellas Strikes Another Deal to Expand in Cancer, Partnering With PeptiDream Astellas Pharma has identified targeted protein degradation as one of the key areas for growth. The PeptiDream alliance is the latest one Astellas has struck in this particular area of drug research as it aims to find new ways to go after difficult cancer targets. Hospitals' Price Transparency Compliance Is Improving Despite Remaining Low at 36% About 36% of U.S. hospitals are in compliance with CMS' price transparency rule, up from 24.5% in February, according to a new report. This progress will remain slow unless CMS can do a better job of effectively enforcing its rule, the report declared.

Resources

Sponsored Content 10 Critical KPIs Every Successful Healthcare Organization is Implementing Learn the top 10 most important contract management KPIs and how to maximize their impact Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe